Inhibition of breast cancer cell motility with a non-cyclooxygenase inhibitory derivative of sulindac by suppressing TGFβ/miR-21 signaling

Compelling efficacy on intervention of tumorigenesis by nonsteroidal anti-inflammatory drugs (NSAIDs) has been documented intensively. However, the toxicities related to cyclooxygenase (COX) inhibition resulting in suppression of physiologically important prostaglandins limit their clinical use for...

Descripción completa

Detalles Bibliográficos
Autores principales: Yi, Bin, Chang, Hong, Ma, Ruixia, Feng, Xiangling, Li, Wei, Piazza, Gary A., Xi, Yaguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884969/
https://www.ncbi.nlm.nih.gov/pubmed/26769851
http://dx.doi.org/10.18632/oncotarget.6888

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884969/
https://www.ncbi.nlm.nih.gov/pubmed/26769851
http://dx.doi.org/10.18632/oncotarget.6888

Ejemplares similares